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This study assessed the relative screening performance of the Dis-
tress Impact Thermometer (DIT) and cutoff levels with the estab-
lished clinical case threshold of the Hospital Anxiety and Depres-
sion Scale (HADS) among a sample of colorectal cancer (CRC)
survivors. Fifty-nine CRC survivors completed the DIT, HADS, and
provided demographic information at baseline, and 45 of these
patients completed the same measures at follow-up, giving a total
of 104 participant data. Receiver operating characteristic (ROC)
analysis was performed to determine the accuracy of the DIT com-
pared to the HADS, with a cutoff score ≥8 on each HADS subscale
(depression and anxiety) and ≥15 on the HADS total scale used to
identify patients with psychological distress. The sample comprised
slightly more males (63%) than females, with an average age of 59
years (SD = 9.53) and ranging from 33 to 77 years. The optimum
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DT cutoff score of ≥5 yielded a sensitivity of 60% and specificity
of 86.1%; the area under the curve was 0.771 (95% confidence
interval [CI] [0.646, 0.896]). For the depression subscale, the DT
performed better on specificity than sensitivity, however the oppo-
site was true for the anxiety subscale. The addition of an impact
thermometer did not enhance screening performance. The results
of this study provide support for a DT score of ≥5 for detecting
psychological distress among CRC survivors and do not support
the addition of an impact thermometer. The use of the DT might
underestimate depression but overestimate anxiety.
KEYWORDS cancer, psychological distress, anxiety, screening,
psychometric performance, survivors, colorectal
INTRODUCTION
Many cancer survivors experience negative psychological effects from their
disease, and improving cancer survivors’ access to psychosocial care remains
a significant concern (Feuerstein, 2007; Holland & Reznik, 2005). To increase
access to psychosocial care for cancer survivors, screening for distress needs
to be integrated into routine patient care. The Distress Thermometer (DT)
(Roth et al., 1998) is a brief and simple screening tool that has been verified
as acceptable and useful for a range of patient groups, including prostate
cancer patients (Roth et al., 1998), patients about to undergo a bone mar-
row transplant (Ransom, Jacobsen, & Booth-Jones, 2006), and mixed cancer
populations (Hoffman, Zevon, D’Arrigo, & Cecchini, 2004).
The DT has been compared to a variety of measures, including the
Hospital Anxiety and Depression Scale (HADS) (Gessler et al., Gil, Grassi,
Travado, Tomamichel, & Gonzalez, 2005; Jacobsen et al., 2005; Ozalp,
Cankurtaran, Soygu¨r, Geyik, & Jacobsen, 2007), the Brief Symptom Inventory
(BSI) (Hoffman et al., 2004), the Center for Epidemiologic Studies Depression
Scale (CES-D) (Ransom et al., 2006), and the State-Trait Anxiety Inventory-
State (STAI-S) (Ransom et al., 2006). Much of this work has involved newly
diagnosed patients and those currently undergoing treatment (Gessler et al.,
2008; Hegel et al., 2008; Ransom et al., 2006).
The appropriate cutoff score for the DT has mainly been assessed rela-
tive to the HADS with a cutoff score of 4 or 5 suggesting optimal sensitivity
and specificity (Gessler et al., 2008; Gil et al., 2005; Jacobsen et al., 2005;
Ozalp et al., 2007). In previous research, the total HADS score has been used;
however few studies have assessed the performance of the DT to detect de-
pression or anxiety individually through the HADS subscales. A recent study
suggested that the DT correlated more strongly and produced a greater area
under receiver operating characteristic (ROC) curve for the HADS total than
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Sensitivity and Specificity of the Distress Impact Thermometer 233
for the anxiety or depression subscales. This was particularly evident on the
depression subscale (Patrick-Miller, Broccoli, Levine, & Much, 2004).
The utility of the DT to detect anxiety and depression is important,
as studies assessing levels of anxiety and depression have shown that pa-
tients’ experience these in different levels. Some studies suggest patients are
more likely to be suffering anxiety than depression during and into the sur-
vivorship phase of the condition (Loge, Abrahamsen, Ekeberg’, Hannisdal,
& Kaasa, 2007; Trask et al., 2002). Despite its widespread acceptance as
a diagnostic tool and its high sensitivity, the DT is limited by poor speci-
ficity (Mitchell, 2007). In view of the cost and resources required for assess-
ment and treatment after screening, specificity is as important for screening
as sensitivity (Bauwens, Baillon, Distelmans, & Theuns, 2009). Modifica-
tions to the DT, such as the addition of an Impact Thermometer (IT) have
sought to improve specificity without sacrificing brevity and good sensitivity
(Akizuki, Yamawaki, Akechi, Nakano, & Uchitomi, 2005). However, evidence
of the additional benefit of the IT is mixed. In a Japanese study involving
275 cancer patients, Akizuki and colleagues demonstrated that the IT added
value over the DT alone (Akizuki et al., 2005). Conversely, Baken, Woolley,
and Kent (2008) found that the IT did not improve the accuracy of the DT
in identifying anxiety or distress but improved its accuracy in identifying
depression.
There are no data on the use of the DT alone or with the IT as a
screening tool for colorectal cancer (CRC) survivors and there are limited
data on the DT’s specificity and sensitivity to detect anxiety and depression.
The current study defined survivor as a patient who has completed active
treatment. It extends previous research on the use of the DT in three ways;
first, by investigating the accuracy of the DT as a screening measure in a
new population group, adult CRC survivors (Livingston et al., 2010); second,
by examining the ability of the DT to detect anxiety and depression individ-
ually; and third, by examining any additional benefit of including the IT in
screening. Using the HADS as a criterion measure of psychological distress,
the current study compared agreement between the DT, IT, and the HADS in
correctly identifying survivors who report significant psychological distress
and investigates the appropriateness of previously proposed DT case rules
for this particular survivor population.
METHOD
Procedures
This was a prospective, multicenter study, involving public and private health
services across Melbourne, Victoria. Eligible patients had potentially curable
CRC, were age 18 years and older, able to speak and read in English, and
nearing completion of postoperative adjuvant chemotherapy. Patients were
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identified from ambulatory chemotherapy units by oncology nurses assigned
to recruit eligible patients. At the second-to-last chemotherapy cycle, the on-
cology nurse asked eligible patients if they would like to be involved in a
study to evaluate a telephone support service. The cancer nurse gave the
patient the participant information and consent form to take home and read.
At the final treatment cycle, patients who wanted to be involved in the
study completed the consent form, as well as the baseline questionnaire.
Participant details were given to the helpline nurse, who followed the stan-
dardized intervention protocol and telephoned participants 7 to 10 days after
recruitment (outcall one) and 4 weeks later (outcall two).
Study questionnaires were self-administered at baseline and adminis-
tered through a telephone interview by an experienced interviewer approx-
imately 2 months after baseline.
Ethical approval was received from Deakin University, The Cancer
Council Victoria, and each of the participating public and private health
services prior to commencement of the study.
Measures
The main outcome measures were anxiety and depression measured using
the HADS (Zigmond & Snaith, 1982) and distress measured using the DIT
(Roth et al., 1998). The HADS consists of two subscales, one assessing de-
pression (seven items) and one anxiety (seven items), with scores ranging
from 0 (no distress) to 21 (maximum distress) for each scale. Scores of 11
or more on either subscale are considered to be significant “cases” of psy-
chological morbidity, whereas scores of 8 to 10 represent “borderline” and
0 to 7 “normal” (Hopwood, Howell, & Maguire, 1991; Kugaya et al., 2000).
The HADS has been used in many research settings and clinical studies,
particularly with cancer patients (Love, Grabsch, Clarke, Bloch, & Kissane,
2004).
The DT is a single-item self-administered rating scale that is represented
by a “thermometer” assessing levels of distress, scored along an 11-point
Visual Analogue Scale, with scores ranging from 0 to 10 (Roth et al., 1998).
The IT is a 1-item questionnaire with an 11-point scale that has the same
thermometer-like format as the DT. Again, scores range from 0 to 10, and
higher scores indicate less favorable status (Akizuki et al., 2005).
Statistical Methods
Patients’ demographic characteristics, including age, sex, employment sta-
tus, and marital status were obtained at baseline. Descriptive statistics were
used to determine sample characteristics and levels of distress and depres-
sion. Due to the dispersed nature of the data, Mann-Whitney U tests and
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chi-squared tests compared the demographics and outcome scores of those
who did and did not complete follow-up.
ROC analysis was used to examine the sensitivity and specificity of DIT
scores against clinically significant thresholds for moderate depression and
anxiety defined by HADS depression and anxiety subscale scores of ≥8 and
total HADS of ≥15 (Hopwood et al., 1991; Kugaya et al., 2000). The ROC
curve measures the ability of a test to discriminate between cases and non-
cases by plotting the sensitivity against 1 − specificity, where sensitivity is
the proportion of true positives that test positive and specificity is the pro-
portion of true negatives that test negative (Razavi, Delvaux, Farvacques, &
Robaye, 1990). The area under the curve (AUC) represents the probability
that a randomly selected case will score higher than a randomly selected
noncase and was estimated using a clustered bootstrap procedure to adjust
for repeated measures on respondents (Pepe, Longton, & Janes, 2009). Opti-
mal cutoffs for balancing DT sensitivity and specificity were calculated using
Youden’s index and were also identified as the point on the curve closest
to (0, 1); in all cases these two methods yielded the same cutoffs. Pearson’s
correlation coefficients were used to test the relationship between DIT and
HADS total, HADS anxiety, and HADS depression scale scores. All statistical
analyses were performed using Stata 11.0 and SPSS 18.0 for Windows.
RESULTS
Sample
Sixty-eight CRC patients were approached to be involved in the study, of
which 59 (87%) agreed to participate. Forty-five participants completed the
follow-up interview. Reasons for loss to follow-up included significant illness,
could not be contacted, deceased, and recommencement of chemotherapy
cycles. There were no significant differences between those who did and
did not complete follow up in terms of age, gender, baseline anxiety and
depression, and distress (Livingston et al., 2010).
To enhance power, we analyzed baseline and follow-up measures to-
gether to provide a total of 104 valid responses. At baseline, there were
slightly more males (63%) than females, with an average age of 59 years
(SD = 9.53) and ranging from 33 to 77 years. Three fourths (76%) of partici-
pants were married or in a de facto relationship, and most (78%) were living
with a partner and/or family.
Prevalence of clinically significant distress. When the HADS cutoff
score of ≥15 was used [20, 21], 24% of the participants suffered from clin-
ically significant distress. Using the established cutoff score of ≥8 for the
individual HADS scales, 26% exceeded the anxiety criterion and 19% were
identified as depressed.
D
o
w
n
lo
ad
ed
 B
y:
 [
De
ak
in
 U
ni
ve
rs
it
y]
 A
t:
 0
5:
37
 2
4 
Ju
ne
 2
01
1
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TABLE 1 Sensitivity and Specificity at Each Cutoff Point on the Distress Thermometer (DT)
for the Total Hospital Anxiety and Depression Scale (HADS) and the HADS Subscales of
Depression and Anxiety
HADS Total HADS Depression HADS Anxiety
DT Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity
≥0 100.0 0.0 100.0 0.0 100.0 0.0
≥1 92.0 35.4 90.0 33.3 96.3 37.7
≥2 84.0 51.9 85.0 50.0 88.9 54.6
≥3 72.0 64.6 70.0 61.9 77.8a 67.5a
≥4 60.0 81.0 65.0 79.8 55.6 80.5
≥5 60.0a 86.1a 65.0a 84.5a 55.6 85.7
≥6 36.0 94.9 40.0 94.1 33.3 94.8
≥7 20.0 96.2 30.0 97.6 18.5 96.1
≥8 4.0 97.5 10.0 98.8 3.7 97.4
≥9 4.0 97.5 0.0 100.0 0.0 100.0
Note: aOptimal DT cutoff score for HADS Total, HADS Depression Subscale, and HADS Anxiety Subscale.
Specificity and sensitivity—DT. For the total HADS, a DT cutoff score
of ≥5 yielded the optimal ratio of sensitivity (60.0%) to specificity (86.1%)
and correctly classified 79.8% of patients (Table 1). The alternative cutoff
score of ≥4 also had sensitivity of 60.0%, however specificity was lower at
81.0%.
For a cutoff value of ≥5 on the DT, we obtained a likelihood ratio for
a positive test (LRP) of 4.3 and a likelihood ratio for a negative test (LRN)
of 0.5. We also obtained a positive predictive value (PPV; proportion of
patients with positive test results who are correctly diagnosed) of 57.7% and
a negative predictive value (NPV; proportion of patients with negative test
results who are correctly diagnosed) of 87.2%, with a false-positive rate of
13.9% and a false-negative rate of 40.0%. The AUC was 0.771 (95% confidence
interval [CI] [0.646, 0.896]) (Figure 1). A cutoff score of ≥5 on the DT classified
25.0% of participants as distressed.
In the identification of potential depression, a DT cutoff score of ≥5
yielded the optimal ratio of sensitivity (65.0%) to specificity (84.5%) and
correctly classified 80.8% of patients. For the alternative cutoff of ≥4, the
sensitivity was the same (65.0%); however the specificity was lower at 79.8%
(Table 1). For a cutoff score of ≥5 on the DT, we obtained a LRP of 4.2 and
LRN of 0.4. We also obtained a PPV of 50.0% and a NPV of 91.0%. The AUC
was 0.772 (95% CI [0.618, 0.926]). A cutoff score of ≥5 on the DT, classified
25.0% of participants as depressed.
In the detection of anxiety, a DT cutoff score of ≥3 yielded the optimal
ratio of sensitivity (77.8%) to specificity (67.5%) and correctly classified 70.2%
of patients (Table 1). For a cutoff value of ≥3 for the DT, we obtained a
LRP of 2.4 and a LRN of 0.3. We also obtained a PPV of 45.7% and a NPV of
89.7%. The AUC was 0.795 (95% CI [0.703, 0.887]). A cutoff score of ≥3 on
the DT classified 44.2% of participants as anxious.
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FIGURE 1 Distress Thermometer compared to Hospital Anxiety and Depression Scale total.
Specificity and sensitivity—DT and IT. In this study, the DT performed
better on specificity than sensitivity at cutoff points of 4 and 5. Given this high
specificity, there was little opportunity for the additional IT item to further
increase DT specificity. When examining the specificity and sensitivity of the
IT and DT combined, relative to the HADS total score of ≥15, we found that
sensitivity was lower than that of the DT alone, even at a score of ≥1 for the
IT and the DT. Thus, due to the higher than expected specificity of DT and
the lower sensitivity of the combined IT and DT, further examination of the
IT was not warranted.
Relationship between DT and HADS. The correlation between the DT
and the total HADS was moderate to strong (r = .622, p < 0.001, n =
104), with the correlation between the DT and the depression subscale of
the HADS (r = .539, p < 0.001, n = 104) slightly weaker than the anxiety
subscale of the HADS (r = .590, p < 0.001, n = 104).
DISCUSSION
The current study examined the screening efficacy of the DT, identified the
optimal cutoff for use in CRC survivors, and evaluated any additional benefit
of including the IT. Consistent with National Comprehensive Cancer Net-
work distress guidelines (National Comprehensive Cancer Network, 2005)
and previous studies (Gessler et al., 2008; Gil et al., 2005; Jacobsen et al.,
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238 M. J. Craike et al.
2005; Ozalp et al., 2007), the DT was effective at screening distress, and a
DT cutoff score of ≥5 was the most optimal for identifying clinically signif-
icant distress (as defined by HADS total score). However, when examined
separately, the cutoff varied from ≥3 for anxiety to ≥5 for depression. The
IT did not improve the diagnostic accuracy of screening for distress in this
group.
Although studies of cancer patients before and during treatment have
found the DT to be lower in specificity than sensitivity (Akizuki et al., 2005;
Shim, Shin, Jeon, & Hahm, 2008), we found the opposite. That is, the DT
performed better in regards to specificity than sensitivity at cutoff points of
4 and 5. This suggests that in this survivor population, compared to other
groups, there were fewer patients who do not meet the HADS criteria for
distress who surpassed the DT cutoff score. However, more people in this
survivor population who scored above the HADS threshold for clinically
significant depressive symptomatology were at risk of not being identified
through the cutoff score recommended. This deserves more attention to
ascertain whether this difference is related to the population group under
study.
When examining the subscales of the HADS, the cutoff of ≥5 was also
optimal for the depression subscale of the HADS, however the cutoff was
lower for the anxiety subscale (≥3). For the depression subscale, the DT
performed better on specificity than sensitivity, however the opposite was
true for the anxiety subscale. This indicated that the use of the DT might
underestimate the severity of depression but overestimate the severity of
anxiety. This deserves further attention, as an analysis of 19 studies that used
the DT suggested modest overall accuracy with least success in diagnosing
anxiety disorders, due to overdiagnosis of anxiety (Mitchell, 2007).
In the current study, the IT, which was developed to improve specificity
without sacrificing brevity and good sensitivity of the DT (Akizuki et al.,
2005), was not effective at enhancing the DT. This was mainly the result
of the higher-than-expected specificity of the DT alone. Consistent with the
findings of Baken et al. (2008), the current study did not provide support for
the use of the IT in detecting overall distress.
We found that approximately one in four CRC survivors suffered from
clinically significant distress, with a slightly higher prevalence of anxiety than
depression. The level of depression in the current study was higher than
studies of cancer survivors generally (Boyes, Girgis, Zucca, & Lecathelinais,
2009) and CRC survivors specifically (Lynch, Steginga, Hawkes, Pakenham,
& Dunn, 2008). One explanation for this difference is the short time between
completion of treatment and the measurement of distress in the current study,
compared to other studies of cancer survivors. As expected, the level of
depression in our sample was lower than studies of patients in the treatment
phase of their condition. When comparing the percentage of patients scoring
above the DT cutoff value (using a cutoff value of ≥5), percentages in the
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literature ranged from 30% to 50% (Dabrowski et al., 2007; Kornblith, 1998;
Trask et al., 2002) compared to 25% in the current study.
Similar to others (Loge et al., 1997; Lynch et al., 2008; Trask et al., 2002),
the current study found that a higher proportion of patients and survivors
reported anxiety (26%) than depression (19%).
We found that correlations between the DT and the HADS depression
and HADS anxiety subscales were moderate and similar, with a slightly higher
correlation with anxiety. This suggests that the DT is a stronger measure of
anxiety. The magnitude of the correlations between the DT and the HADS
total and HADS subscales were similar to other studies (Akizuki et al., 2005;
Bauwens et al., 2009).
The current study’s limitations should be acknowledged. Because this
was a feasibility study using a relatively small sample size, its psychometric
properties and screening efficacy would need to be confirmed and further
examined with a larger sample size. As the current study aim was to validate
the DT across a specific and clearly defined cancer population, we did not
collect any information on disease site, stage, or length of disease as we
were not planning to do subanalyses on these variables.
Clinical Implications
Results of the current study support the use of the DT by clinicians to screen
for distress in a population of CRC survivors. When using this instrument, our
findings suggest that a DT score of ≥5 be used to indicate the need for further
investigation or referral to appropriate support services. Clinicians should be
aware that performance of the DT differs for anxiety and depression, such
that it might underestimate depression but overestimate anxiety. The addition
of the impact thermometer does not enhance the DT and is therefore not
recommended.
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